“Bimekizumab 3-Year Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Long-Term Pooled Analysis from Five Phase 3 3b Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s305. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/2451.